Accuracy and efficiency of using artificial intelligence for data extraction in systematic reviews. A noninferiority study within reviews
Lee, D. C. W.; O'Brien, K. M.; Presseau, J.; Yoong, S.; Lecathelinais, C.; Wolfenden, L.; Thomas, J.; Arno, A.; Hutton, B.; Hodder, R. K.
Show abstract
BackgroundSystematic reviews are important for informing public health policies and program selection; however, they are time- and resource-intensive. Artificial intelligence (AI) offers a solution to reduce these labour-intensive requirements for various aspects of systematic review production, including data extraction. To date, there is limited robust evidence evaluating the accuracy and efficiency of AI for data extraction. This study within a review (SWAR) aimed to determine whether human data extraction assisted by an AI research assistant (Elicit(R)) is noninferior to human-only data extraction in terms of accuracy (i.e. agreement) and time-to-completion. Secondary aims included comparing error types and costs. MethodsA two-arm noninferiority SWAR was conducted to compare AI-assisted and human-only data extraction from 50 RCTs chronic disease interventions. Participants were randomised to extract all data required for conducting a review, using either the AI-assisted or human-only method. Accuracy was assessed using a three-point rubric by an independent assessor blinded to group allocation, based on agreement between extracted data and the assessor. Accuracy scores were standardized to a 0-100 scale. Analysis included overall and subgroup accuracy (data group and data type) using paired t-tests. Time-to-completion was self-reported by data extractors. Type of errors were coded by type and severity, and costs were calculated for data extraction, preparation of files, training and the Elicit(R) Pro subscription. ResultsThere was no difference in overall accuracy between the AI-assisted and human-only arms (mean difference (MD) 0.57 (on a 0-100 scale), 95% confidence interval (CI) -1.29, 2.43). Subgroup analysis by data group found AI-assisted to be more accurate than human-only data extraction for data variables describing intervention and control group (MD 4.75, 95% CI 2.13, 7.38), but otherwise no subgroup differences were observed. AI-assisted data extraction was significantly faster (MD 24.82 mins, 95% CI 18.80, 30.84). The AI-assisted arm made similar error types (missed or omitted data: AI-assisted 3.6%, human-only 3.4%) and severity (minor errors: AI-assisted 6.7%, human-only 6.5%) and cost $181.98 less than the human-only data extraction across the 50 studies. ConclusionAI-assisted data extraction using Elicit(R) showed noninferior accuracy, faster completion times, similar error types and severity, and lower costs compared to human-only extraction. These efficiency gains, without loss in accuracy suggest AI-assisted data extraction can replace one human-only data extractor in future systematic reviews of RCTs. Future research should explore different models of AI data extraction such as two AI-assisted extractors or AI-only extractor with human-only extractor, and comparison of AI-assisted to AI-only.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 98%
- Development of the Individual Participant Data (IPD) Integrity Tool for assessing the integrity of randomised trials using individual participant data 96%
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 96%
Similar papers in this journal
- Trials that turn from retrospectively registered to prospectively registered: A cohort study of ‘retroactively prospective’ clinical trial registration using history data 95%
- Development of a consensus extension of the estimands framework for cluster randomised trials (CRT-estimands): results from an international Delphi study 94%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 93%
Similar papers in this journal
- Investigating the use of a one-page infographic to improve recruitment and retention to the BASIL+ Randomised Controlled Trial: A Study Within a Trial (SWAT) 95%
- Application of observational research methods to real-world studies for rare disease drugs: a scoping review protocol 94%
- Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trials 94%
Similar papers in this journal
- Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions 97%
- The devil is in the details: Reporting and transparent research practices in sports medicine and orthopedic clinical trials 96%
- Strategies used to manage overlap of primary study data by exercise-related overviews. Protocol for a systematic methodological review 96%
Similar papers in this journal
- To Include or Not to Include? A prescription from the pharmacy on how to use active learning assisted screening in systematic reviews 94%
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 93%
- Is artificial intelligence for medical professionals serving the patients? Protocol for a mixed method systematic review on patient-relevant benefits and harms of algorithmic decision-making 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.